|
Home | Medical-Newswire.Com:
|
(Medical-NewsWire.com, January 16, 2018 ) According to the report “Global Antiviral Drugs Market” published by Market Data Forecast, the global market has been estimated at $29.16 billion in 2016 and is projected to reach $37.40 billion with CAGR of 5.10% in the forecast period 2016-2021.
For full report refer to http://www.marketdataforecast.com/market-reports/global-antiviral-drugs-market-1587/
Antiviral drugs are a class of medication used specifically for treating viral infections. From the past few years, resistance is observed among viruses against different antiviral drugs with increasing diversity of viruses. This calls for an evolution of antiviral drugs that attack certain viruses specifically at specified targets such as DNA polymerase, Reverse Transcriptase, and NS3 Protease.
These drugs are used for the treatment of various diseases like HIV/AIDS, influenza, hepatitis, and other viral infections. Globally, approximately one million lost their lives due to HIV in 2015. Approximately, 36.7 million people have been suffering from HIV in 2015. Furthermore, as late-stage pipeline drugs are anticipated to hit the market, this further supports the antiviral drugs market growth.
Free sample for the report is available at http://www.marketdataforecast.com/market-reports/global-antiviral-drugs-market-1587/request-sample
The growth factors for this market are the prevalence of life-threatening diseases, increasing support for the development of novel drugs, increase in public awareness towards healthy lifestyle and rise in healthcare expenditure. Companies are investing in research and development in order to create new innovative products which influence the growth of the market.
Segmentation
By Application
• HIV/AIDS.
• Hepatitis.
• Herpes.
• Influenza.
• Others.
By Targets
• DNA polymerase.
• NS3 Protease.
• Reverse transcriptase.
By End Users
• Hospitals/Clinics.
• Research Institutes.
• Laboratory Centers.
By Geography
• Asia-Pacific.
• Europe.
• Latin America.
• Middle-East and Africa.
• North America.
The major companies dominating the global Antiviral Drugs market are Johnson & Johnson (USA), Novartis International AG (Switzerland), Roche Holding AG (Switzerland), Pfizer (USA), Merck and Co. Inc. (USA), GlaxoSmithKline Plc. (United Kingdom), AstraZeneca AB (United Kingdom), Gilead Sciences (USA), and Abbott Laboratories (USA).
Enquire more about the report at http://www.marketdataforecast.com/market-reports/global-antiviral-drugs-market-1587/inquire
The Global Antiviral Drugs Market study offers following deliverables:
• Global Regional and country-level analysis and forecasts of the study market; providing Insights on the major countries/regions in which this industry is blooming and to also identify the regions those are still untapped.
• Segment-level analysis in terms of technology, component, and type along with market size forecasts and estimations to detect key areas of industry growth in detail
• Identification of key drivers, restraints, opportunities, and challenges (DROC) in the market and their impact on shifting market dynamics.
• Study of the effect of exogenous and endogenous factors that affect the global market; which includes broadly demographic, economic, and political, among other macro-environmental factors presented in an extensive PESTLE Analysis.
• Study the microenvironment factors that determine the overall profitability of an Industry, using Porter’s five forces analysis for analyzing the level of competition and business strategy development.
• A comprehensive list of key market players along with their product portfolio, current strategic interests, key financial information, legal issues, SWOT analysis and analyst overview to study and sustain the market environment.
• Competitive landscape analysis listing out the mergers, acquisitions, collaborations in the field along with new product launches, comparative financial studies and recent developments in the market by the major companies.
• An executive summary, abridging the entire report in such a way that decision-making personnel can rapidly become acquainted with background information, concise analysis, and main conclusions.
• Expertly devised analyst overview along with Investment opportunities to provide both individuals and organizations a strong financial foothold in the market.
About us
Market Data Forecast is a firm working in the areas of market research and business intelligence. We have rich experience in research across major industry segments like Healthcare, Agriculture, Food & Beverages etc. and we cater to the needs of both individual and corporate clients. Our research services contribute to key business areas like business process improvement, key decision making and developing an appropriate corporate strategy. We are truly committed to our clients and other stakeholders for providing customized research services of the highest quality all the while being an organization that’s trusted for its integrity, respected for its accountability, and admired for its excellence, by both clients and competitors alike.
Contact:
Abhishek Shukla
Manager (International Business Development)
Market Data Forecast
Direct Line: +1-888-702-9626
Mobile: +91 998 555 0206
Mail: abhishek@marketdataforecast.com
Visit Market Data Forecast Blog @ http://www.marketdataforecast.com/blog/
View latest Press Releases of MDF @ http://www.marketdataforecast.com/press-releases
Market Data Forecast
Abhishek
+1-888- 702-9626
abhishek@marketdataforecast.com
Source: EmailWire.Com 
Source: EmailWire.com
|
|
|
|
